Industry’s rapid response is a reminder to support and protect biopharmaceutical innovation.
To spend $465 million building a new facility in Portage: production starting in 2024.
Apotex chief and wife died from ligature neck compression, deaths called suspicious.
They’re nervous about changes Health Canada will propose for the Patented Medicine Prices Review Board under a review.
Generic manufacturers fear lost business if others win exclusive rights to distribute blockbuster generic drugs.
Quebec pharmaceutical will use the proceeds to permanently repay loan debts.
Revenue decline blamed on lower product sales, currency exchange rates and divestitures.
Construction is expected to be completed in 2017.
Bacteria that causes a potentially fatal form of pneumonia found in cooling towers.
Concerned about manufacturing practices following inspection.
First foreign employee of drugmaker to be accused in investigation announced last July.
And Novartis, GSK joint venture will focus on pain management, coughs, colds, dermatology.
Drug-maker says closure linked to loss of patent exclusivity and improved manufacturing efficiency.
Deal combines chemical company to create larger independent drug manufacturer.
Effect on agri-food and pharmaceutical companies that rely on US regulatory inspections “contained.”